Neogen Corporation (NEOG) Price Prediction 2026–2050

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components.

It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services. This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. Its Animal Safety segment provides reagents and test kits for use in immunoassay production, forensic and animal toxicology, and life science research, as well as colorimetric and chemiluminescent substrates; veterinary instruments and disposables; animal care and other products, including digestive aids and nutritional supplements; rodent and insect control products, and disinfectants; and genomics services, such as DNA genotyping, sequencing, and trait analysis for livestock and companion animals.

This segment sells its products to companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Neogen Corporation (NEOG) is a Healthcare stock with a current price of $8.90 and a market capitalization of $1.94B. It is ranked in 2023. The near-term forecast presents a neutral stance for 2026, with a 30-day range of $7.58 to $10.45 and a current technical picture showing bullish sentiment overall.

The multi-year forecast paints a path of rising averages and bullish sentiment after 2026. In 2026, the min price is $7.00, the avg is $8.90, and the max is $12.06, with a neutral sentiment. By 2027, the avg rises to $12.03 (min $9.64, max $15.84) and the ROI is 35.1 with a bullish sentiment.

In 2028, the avg is $13.64 (min $10.67, max $18.55) and the ROI is 53.2 with bullish sentiment, followed by 2029 with an avg of $13.84 (min $10.61, max $19.31) and ROI of 55.5. The forecast continues higher to 2030 with an avg of $15.63 (min $11.78, max $22.29) and ROI of 75.7, and remains bullish through 2031 (avg $15.95, ROI 79.2), 2032 (avg $16.07, ROI 80.6), and 2033 (avg $20.07, max $30.14, min $14.46, ROI 125.5). By 2034 the avg is $22.86 (min $16.25, max $34.82) with ROI 156.8, and 2035 shows an avg of $24.07 (min $16.90, max $37.17) with ROI 170.5.

The long horizon strengthens to 2040, where the avg is $33.81 (min $22.41, max $55.23) and ROI reaches 279.9, followed by 2050 with an avg of $59.48 (min $35.75, max $105.56) and ROI of 568.3. These are estimates and not guarantees, but the trajectory indicates meaningful upside over the coming years.